Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MUltiple Myeloma Italian ObServational sTudy (MUST)

NCT05742217 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05742217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05742217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MUltiple Myeloma Italian ObServational sTudy (MUST)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
May 26, 2023
Completion date
May 31, 2026
Enrollment
121 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

refractory multiple myeloma, relapse multiple myeloma